NO20084935L - Nikotinbaerende vaksineformulering - Google Patents
Nikotinbaerende vaksineformuleringInfo
- Publication number
- NO20084935L NO20084935L NO20084935A NO20084935A NO20084935L NO 20084935 L NO20084935 L NO 20084935L NO 20084935 A NO20084935 A NO 20084935A NO 20084935 A NO20084935 A NO 20084935A NO 20084935 L NO20084935 L NO 20084935L
- Authority
- NO
- Norway
- Prior art keywords
- nicotine
- bearing
- vaccine formulation
- composition formulations
- stabilizer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical group CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 2
- 229960002715 nicotine Drugs 0.000 title abstract 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 150000002840 non-reducing disaccharides Chemical class 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000005180 public health Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06113895A EP1854478A1 (fr) | 2006-05-12 | 2006-05-12 | Composition vaccinale comprenant des conjugués nicotine-porteur |
| PCT/EP2007/054604 WO2007131972A1 (fr) | 2006-05-12 | 2007-05-11 | Formule de vaccin véhiculant de la nicotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084935L true NO20084935L (no) | 2008-12-15 |
Family
ID=37882366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084935A NO20084935L (no) | 2006-05-12 | 2008-11-24 | Nikotinbaerende vaksineformulering |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090238797A1 (fr) |
| EP (2) | EP1854478A1 (fr) |
| JP (1) | JP2009536936A (fr) |
| KR (1) | KR20090007588A (fr) |
| CN (1) | CN101443038B (fr) |
| AU (1) | AU2007251604B2 (fr) |
| BR (1) | BRPI0711635A2 (fr) |
| CA (1) | CA2650237A1 (fr) |
| EC (1) | ECSP088877A (fr) |
| IL (1) | IL194656A (fr) |
| MA (1) | MA30479B1 (fr) |
| MX (1) | MX2008014398A (fr) |
| MY (1) | MY146654A (fr) |
| NO (1) | NO20084935L (fr) |
| NZ (1) | NZ596572A (fr) |
| RU (1) | RU2465007C2 (fr) |
| TN (1) | TNSN08453A1 (fr) |
| WO (1) | WO2007131972A1 (fr) |
| ZA (1) | ZA200808489B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| US9267937B2 (en) | 2005-12-15 | 2016-02-23 | Massachusetts Institute Of Technology | System for screening particles |
| US9381477B2 (en) | 2006-06-23 | 2016-07-05 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
| JP2010523595A (ja) | 2007-04-04 | 2010-07-15 | マサチューセッツ インスティテュート オブ テクノロジー | ポリ（アミノ酸）ターゲッティング部分 |
| EP1982729A1 (fr) * | 2007-04-20 | 2008-10-22 | Cytos Biotechnology AG | Régime de vaccination pour les vaccins des cellules B |
| EP2630967A1 (fr) | 2007-10-12 | 2013-08-28 | Massachusetts Institute of Technology | Nano-technologie de vaccin |
| US8591905B2 (en) * | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
| US8343497B2 (en) * | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
| PL213166B1 (pl) * | 2008-10-29 | 2013-01-31 | Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk | Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów |
| UY32560A (es) | 2009-04-29 | 2010-11-30 | Bayer Schering Pharma Ag | Inmunoconjugados de antimesotelina y usos de los mismos |
| US9994443B2 (en) | 2010-11-05 | 2018-06-12 | Selecta Biosciences, Inc. | Modified nicotinic compounds and related methods |
| CN103347535B (zh) | 2010-12-02 | 2015-11-25 | 昂科利蒂克斯生物科技公司 | 液体病毒制剂 |
| TW201233803A (en) | 2010-12-02 | 2012-08-16 | Oncolytics Biotech Inc | Lyophilized viral formulations |
| EP2945593A4 (fr) * | 2013-01-15 | 2016-08-31 | Teva Pharma | Procédé de lyophilisation |
| WO2015059147A1 (fr) * | 2013-10-25 | 2015-04-30 | Bayer Pharma Aktiengesellschaft | Nouvelle formulation stable |
| WO2016165831A1 (fr) | 2015-04-17 | 2016-10-20 | Curevac Ag | Lyophilisation de l'arn |
| EP3928800A3 (fr) | 2015-05-20 | 2022-03-23 | CureVac AG | Composition de poudre sèche comprenant de l'arn à longue chaîne |
| CN107635587A (zh) | 2015-05-20 | 2018-01-26 | 库瑞瓦格股份公司 | 包含长链rna的干燥粉末组合物 |
| WO2017047089A1 (fr) * | 2015-09-16 | 2017-03-23 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions vaccinales |
| WO2018050873A1 (fr) | 2016-09-16 | 2018-03-22 | Leukocare Ag | Nouveau procédé de production de produits médicamenteux biopharmaceutiques à faible viscosité et hautement concentrés en formulation liquide |
| EP3512939A1 (fr) | 2016-09-16 | 2019-07-24 | Leukocare AG | Nouveau procédé d'obtention de compositions à base de vecteurs viraux efficaces pour la vaccination ou la thérapie génique |
| EP3797752B1 (fr) * | 2018-05-21 | 2024-07-17 | Chugai Seiyaku Kabushiki Kaisha | Formulation lyophilisée scellée dans un récipient en verre |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1329760C (fr) * | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique |
| JPH05331071A (ja) * | 1992-01-17 | 1993-12-14 | Asahi Chem Ind Co Ltd | カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法 |
| US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
| EP0814843B1 (fr) * | 1995-03-31 | 2003-11-26 | Xenova Research Limited | Conjugues vecteurs de haptene utilises dans une therapie contre l'usage de drogues |
| US6232082B1 (en) * | 1998-12-01 | 2001-05-15 | Nabi | Hapten-carrier conjugates for treating and preventing nicotine addiction |
| AU7658101A (en) * | 2000-07-28 | 2002-02-13 | Cytos Biotechnology Ag | Compositions for inducing self-specific anti-ige antibodies and uses thereof |
| GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| IL165249A0 (en) * | 2002-07-18 | 2005-12-18 | Cytos Biotechnology Ag | Hapten-carrier conjugates and uses thereof |
-
2006
- 2006-05-12 EP EP06113895A patent/EP1854478A1/fr not_active Withdrawn
-
2007
- 2007-05-11 MY MYPI20084429A patent/MY146654A/en unknown
- 2007-05-11 BR BRPI0711635-7A patent/BRPI0711635A2/pt not_active IP Right Cessation
- 2007-05-11 CN CN2007800173140A patent/CN101443038B/zh not_active Expired - Fee Related
- 2007-05-11 WO PCT/EP2007/054604 patent/WO2007131972A1/fr not_active Ceased
- 2007-05-11 MX MX2008014398A patent/MX2008014398A/es active IP Right Grant
- 2007-05-11 AU AU2007251604A patent/AU2007251604B2/en not_active Ceased
- 2007-05-11 NZ NZ596572A patent/NZ596572A/xx not_active IP Right Cessation
- 2007-05-11 US US12/299,487 patent/US20090238797A1/en not_active Abandoned
- 2007-05-11 RU RU2008148830/15A patent/RU2465007C2/ru not_active IP Right Cessation
- 2007-05-11 JP JP2009508393A patent/JP2009536936A/ja not_active Ceased
- 2007-05-11 CA CA002650237A patent/CA2650237A1/fr not_active Abandoned
- 2007-05-11 KR KR1020087027583A patent/KR20090007588A/ko not_active Ceased
- 2007-05-11 EP EP07729056A patent/EP2021024A1/fr not_active Withdrawn
-
2008
- 2008-10-06 ZA ZA200808489A patent/ZA200808489B/xx unknown
- 2008-10-07 IL IL194656A patent/IL194656A/en not_active IP Right Cessation
- 2008-11-10 TN TNP2008000453A patent/TNSN08453A1/en unknown
- 2008-11-11 EC EC2008008877A patent/ECSP088877A/es unknown
- 2008-11-24 NO NO20084935A patent/NO20084935L/no not_active Application Discontinuation
- 2008-11-24 MA MA31407A patent/MA30479B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL194656A (en) | 2011-12-29 |
| TNSN08453A1 (en) | 2010-04-14 |
| CN101443038B (zh) | 2012-07-04 |
| BRPI0711635A2 (pt) | 2011-11-08 |
| EP2021024A1 (fr) | 2009-02-11 |
| AU2007251604A1 (en) | 2007-11-22 |
| US20090238797A1 (en) | 2009-09-24 |
| RU2465007C2 (ru) | 2012-10-27 |
| MA30479B1 (fr) | 2009-06-01 |
| CA2650237A1 (fr) | 2007-11-22 |
| RU2008148830A (ru) | 2010-06-20 |
| AU2007251604B2 (en) | 2010-11-18 |
| MX2008014398A (es) | 2009-02-06 |
| CN101443038A (zh) | 2009-05-27 |
| EP1854478A1 (fr) | 2007-11-14 |
| WO2007131972A1 (fr) | 2007-11-22 |
| IL194656A0 (en) | 2011-08-01 |
| MY146654A (en) | 2012-09-14 |
| NZ596572A (en) | 2013-04-26 |
| ECSP088877A (es) | 2008-12-30 |
| KR20090007588A (ko) | 2009-01-19 |
| JP2009536936A (ja) | 2009-10-22 |
| ZA200808489B (en) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084935L (no) | Nikotinbaerende vaksineformulering | |
| NO20090175L (no) | Stabile laquinimod sammensetninger | |
| ATE464902T1 (de) | Stabile pharmazeutische zubereitungen von montelukast-natrium | |
| NO20075136L (no) | Nye liposompreparater | |
| MY167123A (en) | Conveniently implantable sustained release drug compositions | |
| AR060187A1 (es) | Composicion inmunogenica | |
| BRPI0710508B8 (pt) | composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído | |
| DK1940243T3 (da) | Kostfiberformulering og fremgangsmåde til indgivelse | |
| ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
| BRPI0717498A2 (pt) | Composições, métodos de preparo de uma solução para preparo cirúrgico utilizada para desinfetar uma região pré-operatória, métodos de desinfecção, e dispositivo médico. | |
| UY30789A1 (es) | Derivados de adenina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
| BR112015023391A8 (pt) | formulações de conjugados anticorpo-droga anti-egfr | |
| UY30460A1 (es) | Compuestos terapéuticos | |
| NO20082269L (no) | Nye piperaziner som antimalariamidler | |
| IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
| NO20074933L (no) | Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat | |
| BR112014005134A2 (pt) | composição farmacêutica de dissolução rápida | |
| NO20092998L (no) | Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden | |
| NO20061245L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon | |
| WO2007106746A3 (fr) | Formulations d'écallantide | |
| ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
| AR057946A1 (es) | Formulacion de zonisamida de liberacion sostenidda | |
| AR055838A1 (es) | Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada | |
| BR112015022385A2 (pt) | droga para uma doença respiratória | |
| NO20073071L (no) | Benzotiazolformuleringer og anvendelse av disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |